Form 8-K - Current report:
SEC Accession No. 0001193125-22-086808
Filing Date
2022-03-28
Accepted
2022-03-28 17:01:10
Documents
13
Period of Report
2022-03-28
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 8-K d339413d8k.htm   iXBRL 8-K 25234
  Complete submission text file 0001193125-22-086808.txt   187424

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eftr-20220328.xsd EX-101.SCH 3582
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftr-20220328_def.xml EX-101.DEF 14304
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftr-20220328_lab.xml EX-101.LAB 23534
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftr-20220328_pre.xml EX-101.PRE 15192
7 EXTRACTED XBRL INSTANCE DOCUMENT d339413d8k_htm.xml XML 5739
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 22776208
SIC: 2834 Pharmaceutical Preparations